|Day Low/High||0.04 / 0.04|
|52 Wk Low/High||0.01 / 0.09|
ESS reduces mortality and repeated donor skin harvesting in children
Amarantus-sponsored training for Phase 2 severe burn trial completed with U.S. Army clinical site in late April
OTC Markets Group, President and CEO R. Cromwell Coulson, will speak on panel "Understanding Reg A+ and the 'Mini IPO'"
Companies to hold a Conference Call to discuss the business combination today, March 7, 2015 at 4:30pm ET
Patent issuance will provide intellectual property protection in China for protein therapy, gene therapy and cell therapy applications of MANF